Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pruritus, Urticaria
Clinical narrative: red flashes across her face, down the neck / redness on hips, forearms, and thighs; developed a sore throat,; developed an allergy.; started itching for two nights,; developed hives./ Hives on hips, forearms, and thighs; could not move her body.; not feeling well that day; extreme fatigue, but was not sleepy; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (could not move her body.), MALAISE (not feeling well that day), PRURITUS (started itching for two nights,), URTICARIA (developed hives./ Hives on hips, forearms, and thighs) and ERYTHEMA (red flashes across her face, down the neck / redness on hips, forearms, and thighs) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 091D21A, 046A21A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, the patient experienced MOBILITY DECREASED (could not move her body.), MALAISE (not feeling well that day) and FATIGUE (extreme fatigue, but was not sleepy). On 15-Nov-2021, the patient experienced PRURITUS (started itching for two nights,), URTICARIA (developed hives./ Hives on hips, forearms, and thighs) and HYPERSENSITIVITY (developed an allergy.). On 17-Nov-2021, the patient experienced ERYTHEMA (red flashes across her face, down the neck / redness on hips, forearms, and thighs) and OROPHARYNGEAL PAIN (developed a sore throat,). The patient was treated with METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Adverse event, at a dose of 6 day course; FEXOFENADINE HYDROCHLORIDE (ALLEGRA [FEXOFENADINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (could not move her body.), MALAISE (not feeling well that day), OROPHARYNGEAL PAIN (developed a sore throat,), FATIGUE (extreme fatigue, but was not sleepy) and HYPERSENSITIVITY (developed an allergy.) outcome was unknown, PRURITUS (started itching for two nights,) and URTICARIA (developed hives./ Hives on hips, forearms, and thighs) had not resolved and ERYTHEMA (red flashes across her face, down the neck / redness on hips, forearms, and thighs) had resolved. No concomitant drug details were reported. Patient states she went to urgent care on 17-Nov-2021. If she stops taking Allegra or Benadryl the itching comes back. She cannot go without 2 hours when it wears off.